Fragmatix is developing intrarenal access technology built around a simple premise: what a procedure leaves behind matters as much as what it removes.
Stone disease is rarely a one-and-done problem. When fragments are left in the collecting system after a procedure, they can serve as a nucleus for regrowth — leading to symptoms, repeat imaging, and in many cases, another trip to the OR.
Existing access tools were built around a two-millimetre standard that hasn't moved in years. We think that ceiling is the wrong thing to be optimizing for.
Fragmatix is engineering a multi-lumen renal access sheath that irrigates and aspirates simultaneously — designed to clear larger fragment volumes in a single pass, rather than relying on repeated retrieval cycles.
The design is grounded in careful fluid-dynamics work and iterative prototyping, built to hold up under real procedural conditions rather than just bench testing.
Separate irrigation and aspiration channels working in the same pass, not sequential steps.
Engineered toward clearing fragment sizes beyond today's typical 2mm access ceiling.
Every design pass tested and refined on the bench before it earns a place in the next prototype.
Fragmatix is in active development and is not yet available for clinical use. This page reflects our current research direction, not a commercial product.
Fragmatix was founded by engineers and clinicians who believe the next generation of kidney stone technology should focus not only on reaching the stone, but on ensuring every clinically significant fragment is removed. Our team combines expertise in biomedical engineering, product development, fluid mechanics, medical device commercialization, and endourology to rethink intrarenal access from the ground up.
Co-Founder • ROLE
Brief biography describing your background, research interests, and role within Fragmatix.
Co-Founder • ROLE
Describe their technical expertise and how they contribute to the development of the company's technology.
Co-Founder • ROLE
Highlight the clinical expertise and guidance provided in product development and validation.
Co-Founder • ROLE
Describe their technical expertise and how they contribute to the development of the company's technology.
Co-Founder • ROLE
Describe their technical expertise and how they contribute to the development of the company's technology.
Co-Founder • ROLE
Describe their technical expertise and how they contribute to the development of the company's technology.
Clinician, investor, or potential partner — if you want to follow this program or discuss collaboration, reach out directly.
Email info@fragmatix.ca →